首页> 外文OA文献 >A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients

【2h】

A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients

机译：一种全自动测定以检测泛细胞角蛋白和EML4-ALK融合蛋白在循环肿瘤细胞（CTC）中的表达预测非小细胞肺癌（NSCLC）患者的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Elisabetta Rossi; Michele Aieta; Alfredo Tartarone; Aldo Pezzuto; Antonella Facchinetti; Daniele Santini; Paola Ulivi; Vienna Ludovini; Luciana Possidente; Pasquale Fiduccia; Nadia Minicuci; Rita Zamarchi;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Characterization of PD-L1 expression in circulating tumor cells (CTCs) of non-small cell lung cancer (NSCLC) patients [J] . Krupa R., Lu D., Harvey M., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第Suppla6期

机译：非小细胞肺癌（NSCLC）患者循环肿瘤细胞（CTC）中PD-L1表达的特征
2. Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC). [J] . Decoster L, Schallier D, Everaert H, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2008,第1期

机译：诱导化疗后，通过18-氟脱氧葡萄糖正电子发射断层扫描（18FDG-PET）评估的完整代谢肿瘤反应预测局部晚期非小细胞肺癌（NSCLC）患者的预后良好。
3. Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer. [J] . Leinonen T, Pirinen R, Bohm J, Histology and histopathology . 2008,第4a6期

机译：基质金属蛋白酶2（MMP-2）的表达增加预测非小细胞肺癌的肿瘤复发和不良预后。
4. Enumeration and ALK Investigation of Circulating Tumor Cells in Non-Small Cell Lung Cancer (NSCLC) Patients Using an Effective In Vivo Technology, the GILUPI CellCollector? [C] . Klaus Luecke, Lukasz Gasiorowski, Stefanie Herold, International Molecular Medicine Tri-Conference. . 2015

机译：使用有效的体内技术（Gilupi Cellcollector
5. Mathematical Modeling of Glioblastoma Wound Healing Assay (WHA) and Radiation Response in Non-Small Cell Lung Cancer (NSCLC) [D] . Ghaderi, Nima. 2021

机译：非小细胞肺癌（NSCLC）胶质母细胞瘤伤口愈合测定（WHA）和辐射反应的数学建模
6. A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients [O] . Elisabetta Rossi, Michele Aieta, Alfredo Tartarone, 2021

机译：一种全自动测定以检测泛细胞角蛋白和EML4-ALK融合蛋白在循环肿瘤细胞（CTC）中的表达预测非小细胞肺癌（NSCLC）患者的结果
7. 158: Tumour Response to Stereotactic Body Radiation Therapy (SBRT) as Predictor of Distant Failure and Survival Outcomes in Patients With Stage I Non-Small Cell Lung Cancer (NSCLC) [O] . Tjong Michael, Poon Ian, Faruqi Salman, 2016

机译：158：I期非小细胞肺癌（NSCLC）患者远距离立体定向放射治疗（SBRT）的肿瘤反应是远期失败和生存结果的预测指标

A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients

著录项

引文网络

相似文献

相关主题

期刊订阅